Home

Officers

Annual Meetings

Contact Us

Officers

President

Peter Houghton, Ph.D.
Director, Greehey Children's Cancer Research Institute
UT Health San Antonio
San Antonio, TX 78229
USA

Vice President

Robert Kramer, Ph.D.
Former Vice President, LV Biology
Johnson and Johnson
Consultant to the Pharmaceutical & Biotechnology Industry
Newton, PA
USA

Secretary

James D Winkler, Ph.D.
Vice President
FORMA Therapeutics
500 Arsenal Street
Watertown, MA 02472.
USA

Treasurer

Alan Eastman, Ph.D.
Professor of Pharmacology
Director, Molecular Therapeutics Program
Geisel School of Medicine at Dartmouth
USA

Assistant Treasurer

William J. Placzek, Ph.D.
Assistant Professor, Department of Biochemistry and Molecular Genetics
Director, Central Alabama High-Field NMR Facility
Co-Director, Structural Biology Shared Facility, Cancer Center
The University of Alabama at Birmingham
USA

Board Members

Mary-Ann Bjornsti, Ph.D.
Professor and Chair
Newman H Waters Chair of Clinical Pharmacology
Department of Pharmacology & Toxicology
University of Alabama at Birmingham
USA

Phillip A. Dennis, M.D., Ph.D.
VP, Disease Strategy Head, Lung Cancer
Global Clinical Lead, Lung Cancer Immuno-Oncology
AstraZeneca
1800 Concord Pike,
Wilmington, DE 19803
USA

Susan Galbraith, Ph.D.
Senior Vice President
IMED Oncology
AstraZeneca
Cambridge Science Park,
7Cambridge, United Kingdom

John A. Hickman, D.Sc.
Agon Consulting, Paris
126 Boulevard Pereire
75017 Paris, France

John S. Lazo, Ph.D.
Harrison Distinguished Professor
Departments of Pharmacology and Chemistry
University of Virginia
USA

Zahid H. Siddik, Ph.D.
Professor of Medicine, Parhmacology
Department of Experimental Therapeutics
MD Anderson Cancer Center
1515 Holcombe Boulevard Unit 1950
Houston, TX 77030
USA

Branimir I. Sikic, M.D.
Professor of Medicine, Oncology
Director, Stanford Clinical and Translational Research Unit
Co-director, Stanford University Center for Clinical
and Translational Education and Research (Spectrum)
Stanford University School of Medicine
Stanford, CA 94305
USA

Eli M. Wallace, Ph.D.
Chief Scientific Officer
Peloton Therapeutics
2330 Inwood Road, Suite 226
Dallas, TX 75235-7323
USA